Literature DB >> 21039324

Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP).

Sabine Schipf1, Robin Haring, Nele Friedrich, Matthias Nauck, Katharina Lau, Dietrich Alte, Andreas Stang, Henry Völzke, Henri Wallaschofski.   

Abstract

OBJECTIVE: There is increasing evidence suggesting that low total testosterone concentration is associated with incident type 2 diabetes mellitus (T2DM) in men. The aim of this study was to evaluate the association between total testosterone and incident T2DM in a large population-based cohort.
METHODS: Of 2117 men at baseline, 1589 were followed up 5 years later. Low total testosterone concentration at baseline determined by <10th percentile (10-year age-strata) were used as a risk factor for incident T2DM at follow-up. To evaluate for potential non-response bias, drop out weights were used in sensitivity analysis.
RESULTS: From 1339 men eligible for analyses, 68 (5.1%) developed T2DM. Men with low total testosterone concentration had an increased risk of developing T2DM (odds ratio [OR] 3.4, 95% CI 1.9-6.1), even after adjustment for age, waist circumference and smoking, OR 3.0; (95% CI 1.6-5.7). Recalculated weighted models revealed almost identical estimates indicating no relevant non-response bias. DISCUSSION: Our prospective findings suggest that low total testosterone concentration is associated with incident T2DM in men and might represent a biomarker that might causally be involved in the risk of T2DM. This underlines the importance of measuring total testosterone in men as the predominant male sex hormone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039324     DOI: 10.3109/13685538.2010.524955

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  7 in total

1.  Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham Heart Study.

Authors:  R Haring; V Xanthakis; A Coviello; L Sullivan; S Bhasin; H Wallaschofski; J M Murabito; R S Vasan
Journal:  Int J Androl       Date:  2012-05-29

2.  Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.

Authors:  K J Mather; C Kim; C A Christophi; V R Aroda; W C Knowler; S E Edelstein; J C Florez; F Labrie; S E Kahn; R B Goldberg; E Barrett-Connor
Journal:  J Clin Endocrinol Metab       Date:  2015-07-22       Impact factor: 5.958

Review 3.  Endogenous sex hormones, metabolic syndrome, and diabetes in men and women.

Authors:  Catherine Kim; Jeffrey B Halter
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

Review 4.  Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications.

Authors:  Anne M Beatrice; Deep Dutta; Manoj Kumar; Shivaprasad Kumbenahalli Siddegowda; Ankur Sinha; Sayantan Ray; Subhankar Chowdhury
Journal:  Diabetes Metab Syndr Obes       Date:  2014-10-20       Impact factor: 3.168

5.  Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis.

Authors:  Qiu-Ming Yao; Bin Wang; Xiao-Fei An; Jin-An Zhang; Liumei Ding
Journal:  Endocr Connect       Date:  2017-12-12       Impact factor: 3.335

Review 6.  Burden of Male Hypogonadism and Major Comorbidities, and the Clinical, Economic, and Humanistic Benefits of Testosterone Therapy: A Narrative Review.

Authors:  Sandy Yeo; Katsiaryna Holl; Nicolás Peñaherrera; Ulrike Wissinger; Kate Anstee; Robin Wyn
Journal:  Clinicoecon Outcomes Res       Date:  2021-01-12

7.  Men with Latent Autoimmune Diabetes and Type 2 Diabetes May Have Different Change Patterns in Free Testosterone.

Authors:  Bo Ding; Feng-Fei Li; Xiao-Fang Zhai; Lei Ye; Yun Hu; Jian-Hua Ma
Journal:  Biomed Res Int       Date:  2020-07-24       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.